WHO ICTRP trial
Genetic Markers of Response to Newer Therapies for Type 2 Diabetes
DRKS00034478 · German Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | DRKS00034478 |
|---|---|
| Public title | Genetic Markers of Response to Newer Therapies for Type 2 Diabetes |
| Scientific title | Genetic Markers of Response to Newer Therapies for Type 2 Diabetes |
| Primary sponsor | Faculty of Medicine, University of Ljubljana |
| Registry | German Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Countries | Slovenia |
| Conditions | E11;Type 2 diabetes mellitus |
| Interventions | Group 1: Patients with T2DM were prescribed SGLT2 inhibitors and/or GLP-1RA inhibitors for 3-6 months and underwent genetical testing for related polymorphisms and clinical testing for treatment response evaluation. |
| Registration date | Jun 14, 2024 |
| Target size | 150 |
| Registry page | drks.de |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: